Kite Pharma, Inc. Deferred Tax Assets, Gross
Kite Pharma, Inc. had Deferred Tax Assets, Gross of $45.10 million as of 2015-12-31, per its 10-K filed 2016-02-29.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGross · last filed 2016-02-29
- 2015-12-31: Deferred Tax Assets, Gross $45.10M.
- 2014-12-31: Deferred Tax Assets, Gross $18.52M.
- 2013-12-31: Deferred Tax Assets, Gross $5.86M.
| Period end | Deferred Tax Assets, Gross |
|---|---|
| 2015-12-31 | $45.10M 10-K · filed 2016-02-29 |
| 2014-12-31 | $18.52M 10-K · filed 2016-02-29 |
| 2013-12-31 | $5.86M 10-K · filed 2015-03-26 |